Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

por Boyer, S., Nishimwe, M. L., Sagaon-Teyssier, L., March, L., Koulla-Shiro, S., Bousmah, M.-Q., Toby, R., Mpoudi-Etame, M. P., Ngom Gueye, N. F., Sawadogo, A., Kouanfack, C., Ciaffi, L., Spire, B., Delaporte, E.
Publicado 2019